Generics 22

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Artemether manufacturers

22 products found

Filters

Filters

Filters , active

Country of origin : Pakistan

Clear all

22 products found

artemether + lumefantrine

Granules for oral suspension 15 mg + 90 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

artemether

Injection 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

artemether + lumefantrine

Tablets 40 mg + 240 mg, 80 mg + 480 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

artemether + lumefantrine

Capsules 40 mg + 240 mg, 20 mg + 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

artemether + lumefantrine

Granules for oral suspension 15 mg + 90 mg, 30 mg + 180 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

artemether + lumefantrine

Tablets 40 mg + 240 mg, 80 mg + 480 mg, 20 mg + 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

artemether

Ampoules, injection 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

artemether + lumefantrine

Granules for oral suspension 15 mg + 90 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

artemether + lumefantrine

Tablets 40 mg + 240 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

artemether + lumefantrine

Tablets 80 mg+480 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
United Kingdom
Manufacturer #18910

Manufacturer usually replies in 5 days

artemether + lumefantrine

Tablets 40 mg+240 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
United Kingdom
Manufacturer #18910

Manufacturer usually replies in 5 days

artemether + lumefantrine

Tablets 20 mg + 120 mg, 40 mg + 240 mg, 80 mg + 480 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17805

Manufacturer usually replies in 2 days

artemether

Solution for injection 80mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17805

Manufacturer usually replies in 2 days

artemether + lumefantrine

Tablets 20 mg + 120 mg, 40 mg + 240 mg, 80 mg + 480 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17750

Manufacturer usually replies in 4 days

artemether + lumefantrine

Oral suspension 15 mg - 60ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17750

Manufacturer usually replies in 4 days

artemether

Vials, injection 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17750

Manufacturer usually replies in 4 days

artemether + lumefantrine

Granules for oral suspension 30 mg + 180 mg, 15 mg + 90 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, Nigeria, Pakistan, Kenya, Uganda, Ghana, Ivory Coast
Manufacturer #21095

Manufacturer usually replies in 6 days

artemether + lumefantrine

Tablets 20 mg + 120 mg, 40 mg + 240 mg, 80 mg + 480 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, Nigeria, Pakistan, Kenya, Uganda, Ghana, Ivory Coast
Manufacturer #21095

Manufacturer usually replies in 6 days

artemether

Injection 20 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, Nigeria, Pakistan, Kenya, Uganda, Ghana, Ivory Coast
Manufacturer #21095

Manufacturer usually replies in 6 days

artemether + lumefantrine

Tablets 40 mg + 240 mg, 80 mg + 480 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, PICS
Manufacturer #21118

Manufacturer usually replies in 12 days

Want to view all 22 products? Create your free account today!

Artemether is a medication used to treat malaria. Although manufacturers of artemether produce drugs with it as the standalone ingredient, it is almost always marketed in combination with lumefantrine. Artemether suppliers market it in the form of oral tablets as well as injectable solutions. The developer and earliest manufacturer of artemether/lumefantrine medications is Novartis, who markets it under the trade name Coartem. The standalone formulation was first introduced into medical use in 1987, whereas the artemether/lumefantrine combination formulation was first approved in 1992. Both drugs have since gained approvals in over 80 countries worldwide, including the U.S., China, numerous African countries and across Europe. What is more, the drug has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Alternatives to artemether are other artemisinin class malaria drugs such as dihydroartemisinin and artesunate. The prices of artemether medications are not particularly high. Its wholesale cost in the developing world typically falls into a range of 0,10 EUR to 1,00 EUR per daily treatment dose.